Mj. Whitaker, CONSENSUS GUIDELINES FOR EVALUATING AND TREATING PATIENTS WITH UPPER GASTROINTESTINAL SYMPTOMS IN THE PRIMARY-CARE SETTING, PharmacoEconomics, 14, 1998, pp. 5-10
Upper gastrointestinal (UGI) disease represents a significant part of
the primary care physician's workload and is ultimately responsible fo
r a major portion of the costs relating to his or her drug prescribing
. This paper outlines the scale of the problem and the possibility of
a structured management plan for UGI disease. Although this type of st
rategy is not new, the International Gastro Primary Care Group (IGPCG)
has approached it from a practical standpoint that addresses the conc
erns of general practitioners and the fears and anxieties of patients.
In addition, the direct representation of this model with a cost-effe
ctive programme is the first opportunity to develop strategies, in pri
mary care, for testing a protocol for the management of UGI disease. T
he approach is aimed at the primary care setting and is adaptable for
use in different cultural groups and healthcare systems.